VisionPoint Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
VisionPoint Advisory Group's LLY Position: Q2 2026 in Review
VisionPoint Advisory Group increased its Eli Lilly (LLY) stake by 104% in Q2 2026, buying an estimated $2.22M and bringing the position to 4,262 shares worth $5.11M. The position accounts for 0.83% of the portfolio, ranked #24.
VisionPoint Advisory Group first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 2,000 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- VisionPoint Advisory Group held 4,262 shares of Eli Lilly worth $5.11M as of Q2 2026.
- VisionPoint Advisory Group bought 2,175 Eli Lilly shares in Q2 2026, an estimated $2.22M.
- Eli Lilly made up 0.83% of VisionPoint Advisory Group's portfolio in Q2 2026, its #24 holding.
- VisionPoint Advisory Group first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
- 2,000 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on VisionPoint Advisory Group's 13F filing for Q2 2026, filed 7 Jul 2026.